Survival of the Fittest: Patient Recruitment and Retention for Clinical Trials Article Published In Journal for Clinical Studies January 2009 Issue
Feb 1, 2009
by Liz Moench
Biopharmaceutical companies must consider three critical steps: how to manage their clinical trials wisely, preserve cash reserves as long as possible, and mitigate risk. These are issues of increasing ramification in today’s economic environment. The risk of failure is great; eighty percent of clinical trials fail due to lack of patient enrolment, yet effective planning can prevent this from occurring, and the financial consequences associated with study delay can be avoided.
Related News:
A Distrust of Western Medicine and Its Effects on Clinical Protocols and Patient Recruitment
Patients Lost Can Be Found: the recruitment-retention and reconnection of patients for clinical
Perspectives on the Role of Patient Advocacy Groups in Patient Recruitment for Clinical Trials
Related Portfolio:
Certified by WBENC (Women's Business Enterprise National Council)